Indoco Remedies

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
231.80
-1.55 (-0.66%)
BSENSE

Nov 20

BSE+NSE Vol: 1.62 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Fredun Pharma
Syncom Formul.
Sakar Healthcare
Ind-Swift Labs.
Windlas Biotech
Beta Drugs Ltd
Hikal
Indoco Remedies
Advanced Enzyme
Sai Parenteral's
Panacea Biotec
Why is Indoco Remedies Ltd ?
1
Weak Long Term Fundamental Strength with a -30.11% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 5.21 times
  • The company has been able to generate a Return on Equity (avg) of 5.91% signifying low profitability per unit of shareholders funds
2
Flat results in Sep 26
  • INTEREST(9M) At Rs 101.12 cr has Grown at 32.49%
  • DEBTORS TURNOVER RATIO(HY) Lowest at 3.47 times
3
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -0.67% over the previous quarter and collectively hold 18.28% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
4
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -7.85% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Indoco Remedies for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Indoco Remedies
-7.85%
-0.15
52.27%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
6.23%
EBIT Growth (5y)
-30.11%
EBIT to Interest (avg)
4.41
Debt to EBITDA (avg)
4.96
Net Debt to Equity (avg)
0.99
Sales to Capital Employed (avg)
1.04
Tax Ratio
30.31%
Dividend Payout Ratio
-2.50%
Pledged Shares
0
Institutional Holding
18.28%
ROCE (avg)
8.26%
ROE (avg)
5.91%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
40
Price to Book Value
2.11
EV to EBIT
89.85
EV to EBITDA
18.75
EV to Capital Employed
1.56
EV to Sales
1.66
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
1.74%
ROE (Latest)
-7.59%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Bullish
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company
NET SALES(Q)

Highest at Rs 520.17 cr

-4What is not working for the Company
INTEREST(9M)

At Rs 101.12 cr has Grown at 32.49%

DEBTORS TURNOVER RATIO(HY)

Lowest at 3.47 times

Loading Valuation Snapshot...
Here's what is working for Indoco Remedies
Net Sales - Quarterly
Highest at Rs 520.17 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Here's what is not working for Indoco Remedies
Interest - Nine Monthly
At Rs 101.12 cr has Grown at 32.49%
over preceding nine months period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (Rs cr)

Debtors Turnover Ratio- Half Yearly
Lowest at 3.47 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio